Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07460440 · ClinicalTrials.gov registry record
SPARC - Screening for Lung Cancer With Platelets Via an AI-enabled RNA-based Classifier
A clinical trial, sponsored by University of Utah.
- Not yet
- Registry status
- 240
- Enrollment target
NCT07460440 is a clinical trial that has not yet begun recruiting, run by University of Utah. The registered enrollment target is 240 participants.
The verdict
NCT07460440 has not yet begun recruiting, sponsored by University of Utah.
- NOT YET RECRUITING
- Registry status
- 240 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether combining a unique analytical approach with changes in platelet RNA expression accurately diagnoses lung cancer. Using retrospective platelet transcriptomic data from 522 patients with non-small cell lung cancer (NSCLC, the most common type of lung cancer), an approach that appears to accurately classify lung cancer has been developed. The study will build upon these retrospective analyses to prospectively recruit patients with newly diagnosed lung cancer, obtain platelet RNA samples from whole blood, and perform validation analyses. This research will also test whether this approach accurately distinguishes benign from malignant lung nodules.
Interventions
- DIAGNOSTIC_TEST Platelet RNA-based assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07460440
The ClinicalTrials.gov registry entry for NCT07460440 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Platelet RNA-based assay is the first listed.
NCT07460440 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07460440 about?
NCT07460440 is a clinical study titled "SPARC - Screening for Lung Cancer With Platelets Via an AI-enabled RNA-based Classifier". The purpose of this study is to test whether combining a unique analytical approach with changes in platelet RNA expression accurately diagnoses lung cancer. Using retrospective platelet transcriptomic data from 522 patients with non-small cell lung cancer (NSCLC, the most common type of lung cancer...
What is the current status of trial NCT07460440?
This trial is currently not yet recruiting. The enrollment target is 240 participants. The study started on 2026-06. Estimated completion is 2028-06.
What interventions are being tested in trial NCT07460440?
The interventions under investigation include: Platelet RNA-based assay (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07460440?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.